Mark Lockwood, M.S.N., R.N., C.C.R.C.

Mark Lockwood


PhD student, OHSU School of Nursing
Lives in: Chicago, IL


Focus Areas:

Transplant, information and communication technologies, health disparities, health and technology literacy

Dissertation Topic:

Using information and communication technology to improve care in renal transplant populations.

Dissertation Committee:

Christopher Lee, Ph.D., R.N.

Funding Sources:

2012-1013 Dean’s Scholarship

Professional Organization Memberships

  1. Sigma Theta Tau International, The Honors Society of Nursing (STTI)
  2. International Transplant Nurse Society
  3. Gift of Hope, African American Task Force
  4. University of Chicago Office of Clinical Research Clinical Research Advisory Committee
  5. University of Chicago Nursing Research Committee
  6. Association of Clinical Research Professional (ACRP)

Personal Interests

In my free time I enjoy spending time with my beautiful wife, Tara, and my 2 year old son, Louie. I am interested in fine art photography, though I have been less active since moving to Chicago where I have no space for a darkroom. I also enjoy writing and recording music in my home studio (aka: the closet).


  1. Brennan DC, Hardinger KL, Bohl DL, Lockwood MB, Torrence S, Schuessler R, Gaudreault M, Roby T, Koch MJ, Miller BW, Schnitzler MA, Storch GA: Preemptive vs prophylactic valganciclovir for CMV in renal transplantation: Early results from a randomized, prospective trial. American Society of Nephrology 2004, St. Louis, MO, J Am Soc Nephrol 15, Abstract SA-FC009 pp 23A, 2004.
  2. Brennan DC, Agha I, Bohl DL, Schnitzler MA, Hardinger KL, Lockwood MB, Torrence S, Schuessler R, Roby T, Gaudreault-Keener M, Storch GA: Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant, 5:582-594, 2005.
  3. Hardinger KL, Bohl D, Schnitzler MA, Lockwood MB, Storch GA, Brennan DC: A randomized, pharmacoeconomics trial of tacrolimus versus cyclosporine in combination with Thymoglobulin in renal transplant recipients. Transplantation, 2005; 80: 41-46.

  4. Khoury JA, Storch GA, Bohl DL, Schuessler RM, Torrence SM, Lockwood MB, Gaudreault-Keener M, Koch MJ, Miller BW, Hardinger KL, Schnitzler MA, Brennan DC: Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. American Journal of Transplantation, 2006; 6: 1-10.

  5. Tambur AR, Herrera N, Lockwood M, Abecassis M: Mycophenolate Mofetil as a tool to alter dendritic cell maturation and allo-antigen presentation. World Transplant congress, poster presentation.